IWAZU Yoshitaka

J-GLOBAL         Last updated: Feb 23, 2017 at 12:22
 
Avatar
Name
IWAZU Yoshitaka

Research Interests

 
 

Research Areas

 
 

Published Papers

 
Iwazu Y, Minami T, Kotani K
Angiology   68(3) 189-195   Mar 2017   [Refereed]
Iwazu Y, Komori S, Nagata D
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy   19(1) 97-98   Feb 2015   [Refereed]
Iwazu Y, Muto S, Miyata Y, Ochi M, Tokue A, Asano Y, Kusano E
Clinical nephrology   79(1) 81-84   Jan 2013   [Refereed]
Yamazaki T, Akimoto T, Okuda K, Sugase T, Takeshima E, Numata A, Morishita Y, Iwazu Y, Yoshizawa H, Komada T, Iwazu K, Saito O, Takemoto F, Muto S, Kusano E
Internal medicine (Tokyo, Japan)   53(2) 115-119   2014   [Refereed]
Akimoto T, Shiizaki K, Sugase T, Watanabe Y, Yoshizawa H, Otani N, Numata A, Takeshima E, Yamazaki T, Miki T, Ito C, Pastor JV, Iwazu Y, Saito O, Muto S, Kuro-o M, Kusano E
Clinical and experimental nephrology   16(3) 442-447   Jun 2012   [Refereed]

Misc

 
Iwazu Y, Muto S, Hirahara I, Fujisawa G, Takeda S, Kusano E.
Journal of Hypertension   29(12) 2440-2453   Dec 2011   [Refereed]
Iwazu Y, Muto S, Fujisawa G, Okada K, Nakazawa E, Ishibashi S, Kusano E
Hypertension   51(3) 749-754   2008   [Refereed]

Conference Activities & Talks

 
The Endothelial Progenitor Cell (EPC) Migration Inhibitor FTY720 Auguments Malignant Nephrosclerosis in Deoxycorticosterone Acetate (DOCA)/Salt Hypertension Rats.
IWAZU Yoshitaka
The 45th Annual Meeting of the American Society of Nephrology   Oct 2012   
TISAM, a selective Matrix Metalloproteinase (MMP)-2 Inhibitor, prevents progression of deoxycorticosterone acetate (DOCA) / salt-induced tubulointerstitial fibrosis.
IWAZU Yoshitaka
The 42th Annual Meeting of the American Society of Nephrology   2009   
Matrix metalloproteinase (MMP)-2 induces tubular epithelial cell injury from the urine space and develops deoxycorticosterone acetate (DOCA) / salt-induced tubulointerstitial fibrosis.
IWAZU Yoshitaka
The 40th Annual Meeting of the American Society of Nephrology   2007   
Urinary matrix metalloproteinase (MMP)-2 is a useful marker for the development of deoxycorticosterone acetate (DOCA) / salt-induced tubulointerstitial fibrosis.
IWAZU Yoshitaka
The 39th Annual Meeting of the American Society of Nephrology   2006   
The reduced peritubular capillary (PTC) density associated with renal hypertrophy contributes to the development of deoxycorticosterone acetate (DOCA) / salt-induced tubulointerstitial fibrosis.
IWAZU Yoshitaka
The 39th Annual Meeting of the American Society of Nephrology   2006   
Mineralocorticoid nuclear receptor (MR) antagonist spironolactone (SPL) prevents mineralocorticoid/salt-induced renal injury via inhibition of tubulointerstitial hypoxia.
IWAZU Yoshitaka
The 38th Annual Meeting of the American Society of Nephrology   2005